TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
+13.26%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.71B
AUM Growth
+$351M
(+10%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
21.85%
Holding
5,705
New
583
Increased
2,927
Reduced
1,693
Closed
465
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$138M |
| 2 |
Palantir
PLTR
|
+$21.2M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$20M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$18.1M |
| 5 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$17.4M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$229M |
| 2 |
Meta Platforms (Facebook)
META
|
+$44.8M |
| 3 |
Broadcom
AVGO
|
+$44.2M |
| 4 |
Amazon
AMZN
|
+$39.4M |
| 5 |
Microsoft
MSFT
|
+$34.1M |
Sector Composition
| 1 | Technology | 20.51% |
| 2 | Financials | 11.6% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.7% |
| 5 | Consumer Discretionary | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
3801
Amarin Corp
AMRN
$317M
| $15.8K | ﹤0.01% |
971
+379
| +64% | +$6.15K |
|
3802
HUTCHMED
HCM
$2.93B
| $15.7K | ﹤0.01% |
1,042
+12
| +1% | +$181 |
|
3803
The Oncology Institute
TOI
$292M
| $15.7K | ﹤0.01% |
7,649
-1,894
| -20% | -$3.88K |
|
3804
Werewolf Therapeutics
HOWL
$68.1M
| $15.7K | ﹤0.01% |
14,377
+5,235
| +57% | +$5.71K |
|
3805
Nautilus Biotechnolgy
NAUT
$86M
| $15.6K | ﹤0.01% |
21,581
+10,827
| +101% | +$7.85K |
|
3806
Ezcorp Inc
EZPW
$1.08B
| $15.6K | ﹤0.01% |
1,127
-6,067
| -84% | -$84.2K |
|
3807
Tenaya Therapeutics
TNYA
$230M
| $15.6K | ﹤0.01% |
25,580
+2,850
| +13% | +$1.74K |
|
3808
Gyre Therapeutics
GYRE
$658M
| $15.6K | ﹤0.01% |
2,124
+1,075
| +102% | +$7.9K |
|
3809
iShares MSCI Japan ETF
EWJ
$15.8B
| $15.6K | ﹤0.01% |
208
+29
| +16% | +$2.17K |
|
3810
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$163M
| $15.6K | ﹤0.01% |
480
-13,781
| -97% | -$447K |
|
3811
TTEC Holdings
TTEC
$181M
| $15.5K | ﹤0.01% |
3,226
-123
| -4% | -$592 |
|
3812
Air Lease Corp
AL
$7.11B
| $15.5K | ﹤0.01% |
265
-1,379
| -84% | -$80.7K |
|
3813
VistaGen Therapeutics
VTGN
$91.4M
| $15.4K | ﹤0.01% |
+7,721
| New | +$15.4K |
|
3814
Brown-Forman Class A
BF.A
$12.7B
| $15.4K | ﹤0.01% |
561
-162
| -22% | -$4.45K |
|
3815
RAPT Therapeutics
RAPT
$328M
| $15.3K | ﹤0.01% |
1,918
+171
| +10% | +$1.37K |
|
3816
iShares Preferred and Income Securities ETF
PFF
$14.8B
| $15.3K | ﹤0.01% |
500
+432
| +635% | +$13.3K |
|
3817
FiscalNote
NOTE
$63.1M
| $15.3K | ﹤0.01% |
2,373
+1,394
| +142% | +$8.97K |
|
3818
Designer Brands
DBI
$205M
| $15.3K | ﹤0.01% |
6,414
+3,690
| +135% | +$8.78K |
|
|
AFCG
3819
AFC Gamma
AFCG
$100M
| $15.3K | ﹤0.01% |
3,405
+1,708
| +101% | +$7.65K |
|
|
ARTV
3820
Artiva Biotherapeutics
ARTV
$70.3M
| $15.2K | ﹤0.01% |
10,098
+7,484
| +286% | +$11.3K |
|
3821
SPDR Portfolio Emerging Markets ETF
SPEM
$14.1B
| $15.2K | ﹤0.01% |
+356
| New | +$15.2K |
|
|
IGMS
3822
DELISTED
IGM Biosciences
IGMS
| $15K | ﹤0.01% |
13,436
+6,217
| +86% | +$6.96K |
|
|
FFAI
3823
Faraday Future Intelligent Electric
FFAI
$261M
| $15K | ﹤0.01% |
8,937
+8,837
| +8,837% | +$14.8K |
|
3824
iShares MSCI Switzerland ETF
EWL
$1.32B
| $14.9K | ﹤0.01% |
272
+172
| +172% | +$9.43K |
|
3825
Babcock & Wilcox
BW
$331M
| $14.9K | ﹤0.01% |
15,494
-3,226
| -17% | -$3.1K |
|